Acorda Therapeutics, Inc. Annual Interest Expense in USD from 2010 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of the cost of borrowed funds accounted for as interest expense.
Summary
Acorda Therapeutics, Inc. quarterly/annual Interest Expense history and growth rate from 2010 to 2023.
  • Acorda Therapeutics, Inc. Interest Expense for the quarter ending March 31, 2024 was $8.44M, a 11.4% increase year-over-year.
  • Acorda Therapeutics, Inc. Interest Expense for the twelve months ending March 31, 2024 was $32.4M, a 7.25% increase year-over-year.
  • Acorda Therapeutics, Inc. annual Interest Expense for 2023 was $31.5M, a 4.41% increase from 2022.
  • Acorda Therapeutics, Inc. annual Interest Expense for 2022 was $30.2M, a 0.55% increase from 2021.
  • Acorda Therapeutics, Inc. annual Interest Expense for 2021 was $30M, a 1.76% decline from 2020.
Interest Expense, Trailing 12 Months (USD)
Interest Expense, Annual (USD)
Interest Expense, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $31.5M +$1.33M +4.41% Jan 1, 2023 Dec 31, 2023 10-K 2024-04-01
2022 $30.2M +$165K +0.55% Jan 1, 2022 Dec 31, 2022 10-K 2024-04-01
2021 $30M -$539K -1.76% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-15
2020 $30.6M +$8.7M +39.8% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-18
2019 $21.9M +$275K +1.27% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-16
2018 $21.6M +$2.93M +15.7% Jan 1, 2018 Dec 31, 2018 10-K 2020-02-28
2017 $18.7M +$2.14M +12.9% Jan 1, 2017 Dec 31, 2017 10-K 2020-02-28
2016 $16.5M +$1.06M +6.82% Jan 1, 2016 Dec 31, 2016 10-K 2019-02-27
2015 $15.5M +$6.18M +66.6% Jan 1, 2015 Dec 31, 2015 10-K/A 2018-03-09
2014 $9.29M +$7.12M +328% Jan 1, 2014 Dec 31, 2014 10-K 2017-02-27
2013 $2.17M +$290K +15.4% Jan 1, 2013 Dec 31, 2013 10-K 2016-02-29
2012 $1.88M -$1.69M -47.3% Jan 1, 2012 Dec 31, 2012 10-K 2015-02-27
2011 $3.57M -$352K -8.98% Jan 1, 2011 Dec 31, 2011 10-K 2014-03-03
2010 $3.92M Jan 1, 2010 Dec 31, 2010 10-K 2013-02-28
* An asterisk sign (*) next to the value indicates that the value is likely invalid.